Search results
Researchers tie Lebrikizumab to sustained atopic dermatitis treatment effect
Medical Xpress· 3 days agoLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to...
Can Dupilumab Halt Atopic March in Pediatric AD?
Medscape· 3 days agoDupilumab therapy was more effective than conventional treatments in reducing the risk of developing allergic rhinitis or asthma in children with atopic ...
Keymed reports positive data of CM313 in immune thrombocytopenia trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoEarlier this month, Keymed reported long-term efficacy and safety data of a Phase III clinical trial...
What's the MACE Risk With Moderate to Severe Eczema?
Medscape· 3 days agoThe findings contrast with the expectation that increased systemic inflammation in moderate to severe AD would correspond with a higher incidence of...
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 9 hours agoLilly has collaboration agreements with several companies, including Incyte (Olumiant...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 9 hours agoARQT is focused on developing and commercializing treatments for unmet needs in immune-mediated...
Skincare Company Galderma Sees Opportunity in ‘Ozempic Face’
The Wall Street Journal· 6 hours agoSpeedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt...
How to Get Rid of Redness on Face
Time Magazine· 3 days agoGerms, bacteria, temperature fluctuations, harsh weather, and irritants are some of things your skin protects you from. Figuring out the true cause of...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Stableford Capital II LLC
ETF DAILY NEWS· 6 hours agoStableford Capital II LLC decreased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 6.2% in the 1st quarter, Holdings Channel reports. The firm owned 5,038 shares of the company’s stock ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Alaska Permanent Fund Corp
ETF DAILY NEWS· 7 hours agoAlaska Permanent Fund Corp lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange ...